SGA

Sector Gamma AS Portfolio holdings

AUM $306M
This Quarter Return
-2.78%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$447M
AUM Growth
+$447M
Cap. Flow
+$5.03M
Cap. Flow %
1.13%
Top 10 Hldgs %
59.92%
Holding
43
New
3
Increased
15
Reduced
12
Closed
6
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GILD icon
1
Gilead Sciences
GILD
$140B
$52.1M 11.66%
843,427
+161,889
+24% +$10M
MRK icon
2
Merck
MRK
$210B
$37.8M 8.45%
414,338
-84,803
-17% -$7.73M
INCY icon
3
Incyte
INCY
$16.5B
$34.9M 7.81%
459,429
+17,417
+4% +$1.32M
MDT icon
4
Medtronic
MDT
$119B
$26.1M 5.83%
290,521
+84,515
+41% +$7.59M
BMY icon
5
Bristol-Myers Squibb
BMY
$96B
$24M 5.37%
311,696
-21,862
-7% -$1.68M
CAH icon
6
Cardinal Health
CAH
$35.5B
$20.2M 4.51%
385,988
+8,718
+2% +$456K
BSX icon
7
Boston Scientific
BSX
$156B
$19.9M 4.44%
532,735
+137,400
+35% +$5.12M
BIIB icon
8
Biogen
BIIB
$19.4B
$18.9M 4.22%
92,497
+10,552
+13% +$2.15M
CI icon
9
Cigna
CI
$80.3B
$17.5M 3.91%
66,283
+7,913
+14% +$2.09M
ELV icon
10
Elevance Health
ELV
$71.8B
$16.6M 3.7%
34,300
+5,282
+18% +$2.55M
BRKR icon
11
Bruker
BRKR
$5.16B
$15.8M 3.53%
251,042
-910
-0.4% -$57.1K
CVS icon
12
CVS Health
CVS
$92.8B
$15.6M 3.49%
168,111
-30,762
-15% -$2.85M
CNC icon
13
Centene
CNC
$14.3B
$15.4M 3.44%
181,799
-12,865
-7% -$1.09M
ZBH icon
14
Zimmer Biomet
ZBH
$21B
$14.3M 3.19%
135,749
+70,948
+109% +$7.45M
NUVA
15
DELISTED
NuVasive, Inc.
NUVA
$12.2M 2.72%
247,502
-18,533
-7% -$911K
OGN icon
16
Organon & Co
OGN
$2.45B
$12M 2.69%
356,089
+16,351
+5% +$552K
QGEN icon
17
Qiagen
QGEN
$10.1B
$9.52M 2.13%
201,729
-17,497
-8% -$826K
VRTX icon
18
Vertex Pharmaceuticals
VRTX
$100B
$9.43M 2.11%
33,474
+8,716
+35% +$2.46M
SGEN
19
DELISTED
Seagen Inc. Common Stock
SGEN
$8.99M 2.01%
+50,795
New +$8.99M
BMRN icon
20
BioMarin Pharmaceuticals
BMRN
$11.2B
$8.72M 1.95%
105,259
+25,500
+32% +$2.11M
ALNY icon
21
Alnylam Pharmaceuticals
ALNY
$58.5B
$6.25M 1.4%
42,844
-16,407
-28% -$2.39M
IONS icon
22
Ionis Pharmaceuticals
IONS
$6.79B
$6.13M 1.37%
165,439
-23,000
-12% -$852K
BIO icon
23
Bio-Rad Laboratories Class A
BIO
$8.06B
$5.83M 1.31%
11,785
-1,000
-8% -$495K
ABT icon
24
Abbott
ABT
$231B
$5.35M 1.2%
+49,205
New +$5.35M
PFE icon
25
Pfizer
PFE
$141B
$5.24M 1.17%
100,000
-29,738
-23% -$1.56M